{"organizations": [], "uuid": "d330b955dd5405dd80fd57cd0eca625ae7d72480", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-reports-qtrly/brief-dova-pharmaceuticals-reports-qtrly-loss-per-share-0-52-idUSASC0A13Y", "country": "US", "domain_rank": 408, "title": "BRIEF-Dova Pharmaceuticals Reports Qtrly Loss Per Share $0.52", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T23:16:00.000+03:00", "replies_count": 0, "uuid": "d330b955dd5405dd80fd57cd0eca625ae7d72480"}, "author": "", "url": "https://www.reuters.com/article/brief-dova-pharmaceuticals-reports-qtrly/brief-dova-pharmaceuticals-reports-qtrly-loss-per-share-0-52-idUSASC0A13Y", "ord_in_thread": 0, "title": "BRIEF-Dova Pharmaceuticals Reports Qtrly Loss Per Share $0.52", "locations": [], "entities": {"persons": [{"name": "dova pharmaceu", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "brief-dova pharmaceuticals", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Updated 10 minutes ago BRIEF-Dova Pharmaceuticals Reports Qtrly Loss Per Share $0.52 Dova Pharmaceuticals Inc:\n* DOVA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS * QTRLY LOSS PER SHARE $0.52\n* Q1 EARNINGS PER SHARE VIEW $-0.47 â€” THOMSON REUTERS I/B/E/S ", "external_links": [], "published": "2018-05-09T23:16:00.000+03:00", "crawled": "2018-05-09T23:31:04.007+03:00", "highlightTitle": ""}